Insider Transactions Reported by 18 Insiders of CERO THERAPEUTICS HOLDINGS, INC.

Symbol
CERO, CEROW on OTC
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 14 Mar 2025

CERO THERAPEUTICS HOLDINGS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stuart M. Sloan 10%+ Owner $2,197,388 25 Sep 2024
Brian G. Atwood Director $1,000,011 07 Jan 2026
YK Bioventures Opportunities GP I, LLC 10%+ Owner $780,310 11 Dec 2024
Douglas Carl Fisher President $483,000 14 Feb 2024
Daniel E. Geffken Chief Financial Officer $100,020 14 Feb 2024
PHOENIX BIOTECH SPONSOR, LLC 10%+ Owner $100,000 14 Feb 2024
Barbara Kosacz Director $58,280 14 Feb 2024
Caroline M. Loewy Director $58,280 14 Feb 2024
Daniel Corey Chief Technical Officer, Director $26,790 25 Mar 2024
Robyn Rapaport Director $5,000 25 Mar 2024
Kristen Pierce Chief Development Officer 07 Jan 2026
Kathleen Laporte Director 07 Jan 2026
Christopher B. Ehrlich Chairman and CEO, Director 07 Jan 2026
Lindsey Rolfe Director 07 Jan 2026
Charles Ross Carter Chief Financial Officer 28 Jun 2024
Michael Byrnes Director 07 Jan 2026
Andrew Albert Kucharchuk Chief Financial Officer 07 Jan 2026
Shami Patel Director 07 Jan 2026

Recent Insider Transactions by Companies or Individuals for CERO THERAPEUTICS HOLDINGS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Lindsey Rolfe CERO Stock Option (Right to Buy) Award 690,900 690,900 07 Jan 2026 Direct
Kathleen Laporte CERO Stock Option (Right to Buy) Award 690,900 690,900 07 Jan 2026 Direct
Kristen Pierce CERO Stock Option (Right to Buy) Award 1,612,099 1,612,099 07 Jan 2026 Direct
Shami Patel CERO Stock Option (Right to Buy) Award 690,900 690,900 07 Jan 2026 Direct
Brian G. Atwood CERO Stock Option (Right to Buy) Award 1,612,099 1,612,099 07 Jan 2026 Direct
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Award 4,530,997 4,530,997 07 Jan 2026 Direct
Michael Byrnes CERO Stock Option (Right to Buy) Award 690,900 690,900 07 Jan 2026 Direct
Andrew Albert Kucharchuk CERO Stock Option (Right to Buy) Award 1,162,099 1,162,099 07 Jan 2026 Direct
Kathleen Laporte CERO Stock Option (Right to Buy) Award 9,326 9,326 30 May 2025 Direct
Michael Byrnes CERO Stock Option (Right to Buy) Award 9,326 9,326 30 May 2025 Direct
Lindsey Rolfe CERO Stock Option (Right to Buy) Award 9,326 9,326 30 May 2025 Direct
Shami Patel CERO Stock Option (Right to Buy) Award 11,693 11,693 30 May 2025 Direct
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Award 61,843 61,842 30 May 2025 Direct
Brian G. Atwood CERO Stock Option (Right to Buy) Award 122,549 122,549 30 May 2025 Direct
Kristen Pierce CERO Stock Option (Right to Buy) Award 154,841 154,841 30 May 2025 Direct
Andrew Albert Kucharchuk CERO Stock Option (Right to Buy) Award 152,500 152,500 30 May 2025 Direct
Brian G. Atwood CERO Common Stock Options Exercise 150.2% 294,460 490,534 31 Mar 2025 See Footnote
Brian G. Atwood CERO Pre-Funded Warrant Options Exercise 294,460 11,660 31 Mar 2025 Direct
Kathleen Laporte CERO Stock Option (Right to Buy) Award 17,923 17,923 04 Mar 2025 Direct
Lindsey Rolfe CERO Stock Option (Right to Buy) Award 17,923 17,923 04 Mar 2025 Direct
Michael Byrnes CERO Stock Option (Right to Buy) Award 17,923 17,923 04 Mar 2025 Direct
Shami Patel CERO Stock Option (Right to Buy) Award 14,936 14,936 04 Mar 2025 Direct
Brian G. Atwood CERO Stock Option (Right to Buy) Award 14,936 14,936 04 Mar 2025 Direct
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Award 119,486 119,486 04 Mar 2025 Direct
Lindsey Rolfe CERO Stock Option (Right to Buy) Award 100% 127,500 255,000 24 Feb 2025 Direct
Shami Patel CERO Stock Option (Right to Buy) Award 100% 127,500 255,000 24 Feb 2025 Direct
Kathleen Laporte CERO Stock Option (Right to Buy) Award 100% 127,500 255,000 24 Feb 2025 Direct
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Award 100% 1,275,000 2,550,000 24 Feb 2025 Direct
Michael Byrnes CERO Stock Option (Right to Buy) Award 100% 127,500 255,000 24 Feb 2025 Direct
Brian G. Atwood CERO Stock Option (Right to Buy) Award 100% 254,000 508,000 24 Feb 2025 Direct
Brian G. Atwood CERO Warrant to Purchase Shares of Common Stock Award 204,080 204,080 07 Feb 2025 By GVN, LLC
Brian G. Atwood CERO Warrant to Purchase Shares of Common Stock Award 306,120 306,120 07 Feb 2025 Direct
Brian G. Atwood CERO Pre-Funded Warrant Award 204,080 204,080 07 Feb 2025 By GVN, LLC
Brian G. Atwood CERO Pre-Funded Warrant Award 306,120 306,120 07 Feb 2025 Direct
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -18.7% $179,934 $0.0600 -2,998,908 13,005,169 13 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -9.16% $113,018 $0.0700 -1,614,541 16,004,077 12 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -7.09% $107,504 $0.0800 -1,343,801 17,618,618 11 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -7.65% $141,385 $0.0900 -1,570,947 18,962,419 10 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -3.98% $93,560 $0.1100 -850,543 20,533,366 09 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -5.47% $148,425 $0.1200 -1,236,874 21,383,909 06 Dec 2024 By YK Bioventures Opportunities Fund I, L.P.
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Award 1,275,000 1,275,000 02 Dec 2024 Direct
Lindsey Rolfe CERO Stock Option (Right to Buy) Award 127,500 127,500 02 Dec 2024 Direct
Kathleen Laporte CERO Stock Option (Right to Buy) Award 127,500 127,500 02 Dec 2024 Direct
Michael Byrnes CERO Stock Option (Right to Buy) Award 127,500 127,500 02 Dec 2024 Direct
Brian G. Atwood CERO Stock Option (Right to Buy) Award 254,000 254,000 02 Dec 2024 Direct
Shami Patel CERO Stock Option (Right to Buy) Award 127,500 127,500 02 Dec 2024 Direct
YK Bioventures Opportunities GP I, LLC CERO Common Stock Sale -12.6% $325,000 $0.1000 -3,250,000 22,620,783 10 Oct 2024 By YK Bioventures Opportunities Fund I, L.P.
Andrew Albert Kucharchuk CERO Stock Option (Right to Buy) Award 500,000 500,000 01 Oct 2024 Direct
Kristen Pierce CERO Stock Option (Right to Buy) Award 200,000 200,000 01 Oct 2024 Direct
Christopher B. Ehrlich CERO Stock Option (Right to Buy) Disposed to Issuer -100% -572,182 0 30 Sep 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.